Advanced Search

    Technical Analysis for ARMP - Armata Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 2.72 -4.90% -0.14
    ARMP closed down 4.9 percent on Monday, February 6, 2023, on 31 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical ARMP trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    20 DMA Support Bullish 0.00%
    NR7 Range Contraction -4.90%
    NR7-2 Range Contraction -4.90%
    Narrow Range Bar Range Contraction -4.90%
    Wide Bands Range Expansion -4.90%
    NR7 Range Contraction -9.33%
    NR7-2 Range Contraction -9.33%
    Wide Bands Range Expansion -9.33%
    Gapped Up Strength -9.33%
    Older End-of-Day Signals for ARMP ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Down 5% 25 days ago
    Down 3% 25 days ago
    Fell Below Previous Day's Low 25 days ago
    Down 2 % 25 days ago
    Down 1% 25 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators Basic chart:

    Profile

    Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Armata's lead product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. The Company is also developing and advancing a broad pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa, leveraging its proprietary phage-specific GMP manufacturing capabilities.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Antibiotics Bacteria Staphylococcus Aureus Pathogenic Bacteria Pseudomonas Bacteriophage Drug Resistance Gram Negative Bacteria Pseudomonas Aeruginosa Manufacturing Capabilities Multiple Drug Resistance

    Is ARMP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 10 Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC
    Jan 4 Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Dec 22 Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection
    Dec 8 Armata Pharmaceuticals, Inc. (ARMP) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
    Nov 28 After Plunging 35.3% in 4 Weeks, Here's Why the Trend Might Reverse for Armata Pharmaceuticals, Inc. (ARMP)
    Nov 28 Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage
    Nov 15 Here's Why Armata Pharmaceuticals, Inc. (ARMP) Looks Ripe for Bottom Fishing
    Nov 15 Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
    Nov 9 Armata Pharmaceuticals GAAP EPS of -$0.24 beats by $0.04, revenue of $1.34M misses by $0.32M
    Nov 9 Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update
    See more ARMP news...

    Indicators

    Indicator Value
    52 Week High 5.7864
    52 Week Low 0.8311
    Average Volume 24,842
    200-Day Moving Average 3.43
    50-Day Moving Average 2.07
    20-Day Moving Average 2.67
    10-Day Moving Average 3.09
    Average True Range 0.31
    RSI 53.70
    ADX 30.11
    +DI 31.48
    -DI 25.09
    Chandelier Exit (Long, 3 ATRs) 2.83
    Chandelier Exit (Short, 3 ATRs) 2.28
    Upper Bollinger Bands 3.74
    Lower Bollinger Band 1.59
    Percent B (%b) 0.52
    BandWidth 80.69
    MACD Line 0.28
    MACD Signal Line 0.31
    MACD Histogram -0.0256
    Fundamentals Value
    Market Cap 50.87 Million
    Num Shares 18.7 Million
    EPS -0.14
    Price-to-Earnings (P/E) Ratio -19.57
    Price-to-Sales 141.04
    Price-to-Book 2.41
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.20
    Resistance 3 (R3) 3.22 3.08 3.12
    Resistance 2 (R2) 3.08 2.96 3.07 3.09
    Resistance 1 (R1) 2.90 2.88 2.83 2.88 3.07
    Pivot Point 2.76 2.76 2.73 2.75 2.76
    Support 1 (S1) 2.58 2.64 2.51 2.56 2.37
    Support 2 (S2) 2.44 2.56 2.43 2.35
    Support 3 (S3) 2.26 2.44 2.32
    Support 4 (S4) 2.24